GENNEX LABORATORIES LTD. - Board Meeting Outcome for Outcome Of The Board Meeting Held On January 04, 2022 Of Gennex Laboratories Limited

In just concluded Meeting of the Board Directors of the Company, the board has considered and approved: 1. After through discussion on all the recommendations of the Audit Committee, board decided to make Deccan Remedies Limited (Deccan) as our Subsidiary Company by acquire additional 6.73% equity Shares i.e., 836,165 from the Existing promoter Shareholders group and in turn the Company will hold 51% equity shares of the Deccan. 2. Mr. Arihant Baid, Managing Director of the Company represent Gennex (the Company) in the Board of Deccan to manage the Affairs of the Deccan.